CJC-1295 2mg | Growth Hormone-Releasing Peptide | 99% Purity | Third-Party Tested

Product Overview

CJC-1295 (also known as CJC 1295 or Mod GRF 1-29 without DAC) is a synthetic growth hormone-releasing hormone (GHRH) analogue peptide consisting of 29 amino acids. This research-grade peptide has been extensively studied in laboratory settings for its molecular interactions with growth hormone secretagogue receptors and pituitary gland signaling pathways. CJC-1295 is frequently researched alongside Ipamorelin in what is commonly known as the “Growth Hormone Stack” for comprehensive growth hormone pathway research applications.

Our CJC-1295 research peptide is manufactured to the highest standards, with third-party verified purity exceeding 99%. Each vial contains 2mg of lyophilized (freeze-dried) peptide powder, accompanied by a Certificate of Analysis (COA) from an independent laboratory.

Research Applications

CJC-1295 has been the subject of numerous peer-reviewed studies examining its role as a growth hormone-releasing hormone analogue. Research has focused on its molecular binding affinity to GHRH receptors, pituitary gland stimulation mechanisms, and synergistic effects when combined with growth hormone secretagogues. Published studies have investigated CJC-1295’s molecular pathways in cell culture models and laboratory environments.

Research applications include:

• GHRH receptor binding studies: Examination of peptide-receptor interactions and binding kinetics in vitro
• Growth hormone release pathway research: Investigation of pituitary gland stimulation, GH pulse amplitude, and secretion patterns
• Synergistic peptide studies: Often studied in combination with Ipamorelin to examine dual-pathway GH release mechanisms (Growth Hormone Stack)
• Peptide stability and half-life analysis: Study of molecular modifications, plasma stability, and extended release characteristics

Important: This product is intended for laboratory research use only. It is not approved for human consumption, clinical use, or any diagnostic or therapeutic applications. This product is not intended to diagnose, treat, cure, or prevent any disease.

Product Specifications

• Peptide Name: CJC-1295 (Mod GRF 1-29 without DAC)
• Alternative Names: CJC 1295, Modified GRF 1-29, Mod GRF
• Amino Acid Length: 29 amino acids (modified GHRH analogue)
• Molecular Formula: C152H252N44O42
• Molecular Weight: 3367.97 g/mol
• Dosage per Vial: 2mg
• Form: Lyophilized (freeze-dried) white powder
• Purity: >99% (verified by third-party HPLC analysis)
• Storage: Store lyophilized peptide at -20°C. After reconstitution, store at 2-8°C and use within 30 days for optimal stability.
• Packaging: Sterile sealed vial with tamper-evident cap

Quality & Purity Guarantee

Every batch of our CJC-1295 peptide undergoes rigorous third-party testing to ensure maximum purity and quality:

• HPLC Analysis: High-Performance Liquid Chromatography confirms peptide purity >99%
• Mass Spectrometry: Verifies molecular weight and sequence accuracy
• Certificate of Analysis: Each order includes a COA from an independent, accredited laboratory
• Sterility Testing: Ensures product is free from microbial contamination
• Endotoxin Testing: Confirms safe levels for research applications

We are committed to providing researchers with the highest quality peptides for advancing scientific knowledge.

Frequently Asked Questions

What is CJC-1295?

CJC-1295 (also called CJC 1295 or Mod GRF 1-29) is a synthetic growth hormone-releasing hormone analogue consisting of 29 amino acids. It has been extensively studied in preclinical research settings for its ability to stimulate growth hormone release from the pituitary gland through GHRH receptor activation.

What is CJC-1295 used for in research?

CJC-1295 is used in laboratory research to study growth hormone release mechanisms, GHRH receptor binding, and pituitary gland signaling pathways. Research applications include receptor binding assays, GH secretion studies, and synergistic peptide combination analysis. This product is for research purposes only and is not intended for human consumption.

How should CJC-1295 be stored?

Store lyophilized CJC-1295 at -20°C (freezer) for long-term stability. Once reconstituted with bacteriostatic water, store at 2-8°C (refrigerator) and use within 30 days for optimal stability. Avoid repeated freeze-thaw cycles.

Does each vial come with a Certificate of Analysis?

Yes, every batch of our CJC-1295 peptide is tested by an independent, third-party laboratory. Each order includes access to the Certificate of Analysis (COA) verifying purity, molecular weight, and quality specifications.

Can CJC-1295 be combined with Ipamorelin in research?

Yes, CJC-1295 and Ipamorelin are frequently studied together in research settings, commonly referred to as the “Growth Hormone Stack.” This combination allows researchers to examine dual-pathway growth hormone release mechanisms – CJC-1295 stimulates GH release via GHRH receptors while Ipamorelin acts through ghrelin receptors. All research should be conducted in controlled laboratory environments by qualified personnel.

What is the difference between CJC-1295 with DAC and without DAC?

CJC-1295 without DAC (Drug Affinity Complex) is also known as Mod GRF 1-29 and has a shorter half-life, making it suitable for pulsatile GH release studies. CJC-1295 with DAC has an extended half-life due to the addition of a Drug Affinity Complex molecule. This product is CJC-1295 without DAC (Mod GRF 1-29), the more commonly researched variant for studying natural GH pulse patterns.

Research Disclaimer

FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.

This product is sold exclusively for research and laboratory purposes. CJC-1295 is not approved by the FDA for human use, clinical applications, or any diagnostic or therapeutic purposes when sold as a research peptide. This product is not intended to diagnose, treat, cure, or prevent any disease. Researchers should follow all applicable laws, regulations, and institutional guidelines when handling this material.

By purchasing this product, you acknowledge that you are a qualified researcher or acting on behalf of a research institution, and that this peptide will be used solely for in-vitro or laboratory research purposes.

Related Research Peptides

Researchers studying CJC-1295 may also be interested in these complementary peptides:

• Ipamorelin – Growth hormone secretagogue most frequently studied alongside CJC-1295 in the Growth Hormone Stack combination
• BPC-157 (Body Protection Compound-157) – Tissue research peptide with complementary molecular mechanisms
• TB-500 (Thymosin Beta-4) – Actin-binding peptide for cellular research applications
• Semaglutide (GLP-1 Receptor Agonist) – Incretin receptor agonist for metabolic research